Attentional Bias Modification Training for Quitting Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and control groups at post-intervention as compared to the pre-intervention; and (2) test the feasibility and efficacy of the intervention at post-intervention. To accomplish these aims, a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for e-cigarette use.
Who Is on the Research Team?
Seok Hyun Gwon, PhD, RN
Principal Investigator
University of Wisconsin, Milwaukee
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-29 who exclusively use e-cigarettes (ENDS) and have been doing so for at least 3 months. Participants must own a smartphone but cannot be on medication or psychosocial treatment for ENDS dependence, pregnant, have serious alcohol issues, eye-tracking problems, or current psychiatric treatment for DSM-5 mental health disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo attentional bias modification training or placebo attention control training
Follow-up
Participants are monitored for attentional bias, nicotine dependence, and subjective urges for e-cigarette use
What Are the Treatments Tested in This Trial?
Interventions
- Computerized attentional bias modification training
- Placebo attention control training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Milwaukee
Lead Sponsor